- Home
- NCNA vs ADIL Comparison
NCNA vs ADIL Comparison
Compare NCNA & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- ADIL
- Stock Information
- Founded
- NCNA 1997
- ADIL 2010
- Country
- NCNA United Kingdom
- ADIL United States
- Employees
- NCNA N/A
- ADIL N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- NCNA Health Care
- ADIL Health Care
- Exchange
- NCNA Nasdaq
- ADIL Nasdaq
- Market Cap
- NCNA 4.5M
- ADIL 4.8M
- IPO Year
- NCNA 2017
- ADIL 2018
- Fundamental
- Price
- NCNA $0.80
- ADIL $0.67
- Analyst Decision
- NCNA Buy
- ADIL Strong Buy
- Analyst Count
- NCNA 2
- ADIL 1
- Target Price
- NCNA $25.00
- ADIL $8.00
- AVG Volume (30 Days)
- NCNA 39.0K
- ADIL 2.3M
- Earning Date
- NCNA 03-19-2025
- ADIL 03-04-2025
- Dividend Yield
- NCNA N/A
- ADIL N/A
- EPS Growth
- NCNA N/A
- ADIL N/A
- EPS
- NCNA N/A
- ADIL N/A
- Revenue
- NCNA N/A
- ADIL N/A
- Revenue This Year
- NCNA N/A
- ADIL N/A
- Revenue Next Year
- NCNA N/A
- ADIL N/A
- P/E Ratio
- NCNA N/A
- ADIL N/A
- Revenue Growth
- NCNA N/A
- ADIL N/A
- 52 Week Low
- NCNA $0.77
- ADIL $0.61
- 52 Week High
- NCNA $10.79
- ADIL $3.10
- Technical
- Relative Strength Index (RSI)
- NCNA 34.90
- ADIL 39.07
- Support Level
- NCNA $0.79
- ADIL $0.61
- Resistance Level
- NCNA $0.97
- ADIL $0.79
- Average True Range (ATR)
- NCNA 0.08
- ADIL 0.10
- MACD
- NCNA -0.01
- ADIL -0.01
- Stochastic Oscillator
- NCNA 10.71
- ADIL 8.70
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.